Main text As 2022 begins, the COVID-19 pandemic is still ongoing and continuing to impact our lives. Since its initial characterization, the structural biology community has made invaluable contributions towards the understanding of the SARS-CoV-2 virus and its components on a molecular level, facilitating structure-guided antiviral drug discovery and the development of novel therapeutic approaches against COVID-19. These efforts are helped by continuous innovations in the field.